Back to Journals » Therapeutics and Clinical Risk Management » Volume 16

Concomitant Use of rFVIIa and Emicizumab in People with Hemophilia A with Inhibitors: Current Perspectives and Emerging Clinical Evidence

Total article views   Abstract views HTML views PDF downloads Totals
5,355 Dovepress* 3,830 1,214+ 1,302 5,044
PubMed Central* 0 311 153 311
Totals 3,830 1,525 1,455 5,355
*Since 22 May 2020
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
6 1 0 0 2 3

View citations on PubMed Central and Google Scholar